subject: CHEBI:28680

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:28680

subject_name: Cytarabine

object_name: adult acute monocytic leukemia

tested_intervention: unsure


subject: CHEBI:28680

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:28680

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:28680

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:28680

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:28680

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:28680

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:28680

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:28680

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:28680

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:28680

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:28680

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:28680

object_name: Adult Erythroleukemia


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:64153

object_name: chronic myelomonocytic leukemia


subject: CHEBI:64153

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:64153

object_name: Blast Phase


subject: CHEBI:64153

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:64153

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:64153

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:64153

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:64153

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:64153

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:64153

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:64153

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:64153

object_name: adult acute monocytic leukemia


subject: CHEBI:64153

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:64153

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:64153

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:64153

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:64153

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:64153

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:64153

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:64153

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:64153

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:64153

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:64153

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:64153

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:64153

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:64153

object_name: Adult Erythroleukemia


subject: CHEBI:93755

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:93755

object_name: chronic myelomonocytic leukemia


subject: CHEBI:93755

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:93755

object_name: Blast Phase


subject: CHEBI:93755

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:93755

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:93755

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:93755

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:93755

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:93755

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:93755

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:93755

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:93755

object_name: adult acute monocytic leukemia


subject: CHEBI:93755

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:93755

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:93755

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:93755

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:93755

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:93755

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:93755

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:93755

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:93755

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:93755

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:93755

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:93755

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:93755

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:93755

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: PRETEXT I Hepatoblastoma


subject: PUBCHEM.COMPOUND:2767

object_name: PRETEXT II Hepatoblastoma


subject: PUBCHEM.COMPOUND:2767

object_name: PRETEXT IV Hepatoblastoma


subject: PUBCHEM.COMPOUND:2767

object_name: PRETEXT III Hepatoblastoma


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Adult Solid Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: MESH:C037038

subject_name: neotil


subject: CHEBI:31355

subject_name: Carboplatin

object_name: melanoma


subject: UMLS:C0935954

subject_name: Genasense


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic malignant neoplasm to stomach

tested_intervention: yes


subject: UNII:DPT0O3T46P

object_name: Stage IV Esophageal Adenocarcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IV Esophageal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: gastric squamous cell carcinoma


subject: UMLS:C4331953

subject_name: Sigmart

object_name: Angina pectoris


subject: CHEBI:31905

subject_name: Nicorandil


subject: CHEBI:167309

subject_name: Methadone

object_name: neonatal abstinence syndrome


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: glioma


subject: CHEBI:30314

object_name: malignant glioma


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: anxiety


subject: CHEBI:84094

object_name: anxiety disorder


subject: CHEBI:84094

object_name: Anxiety symptoms


subject: CHEBI:84094

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:84094

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: GTOPDB:4985

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:4985

object_name: clear cell renal carcinoma


subject: GTOPDB:4985

object_name: renal cell adenocarcinoma


subject: GTOPDB:4985

object_name: renal cell carcinoma


subject: GTOPDB:4985

object_name: metastatic neoplasm


subject: GTOPDB:4985

object_name: Embolism, Tumor


subject: GTOPDB:4985

object_name: Neoplasm Metastasis


subject: GTOPDB:4985

object_name: Metastatic Lesion


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: diabetic macular edema


subject: UMLS:C5670519

subject_name: Litifilimab

object_name: EXCESS LMW-DNA


subject: GTOPDB:11122

subject_name: litifilimab


subject: UNII:V27E9V3K7G

subject_name: LITIFILIMAB


subject: CHEBI:3752

subject_name: Clomifene

object_name: female infertility


subject: CHEBI:3752

object_name: Encounter due to In vitro fertilization


subject: MESH:C551396

subject_name: pergoveris


subject: MESH:C551396


subject: CHEBI:6843

subject_name: Methoxyflurane

object_name: Acute Pain


subject: CHEBI:6843

object_name: Physical trauma


subject: CHEBI:6843

object_name: Injury


subject: CHEBI:6843

object_name: Trauma


subject: CHEBI:131158

subject_name: Semagacestat

object_name: Alzheimer disease


subject: CHEBI:34911

subject_name: Permethrin

object_name: scabies


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:72317

object_name: clear cell renal carcinoma


subject: CHEBI:72317

object_name: Solid Neoplasm


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: PUBCHEM.COMPOUND:156859185

subject_name: Casdatifan


subject: PUBCHEM.COMPOUND:156859185


subject: PUBCHEM.COMPOUND:156859185


subject: UNII:DP73UWL6LE

subject_name: CASDATIFAN


subject: UNII:DP73UWL6LE


subject: UNII:DP73UWL6LE


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Sturge-Weber syndrome


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: UNII:609AWV0US2

object_name: Non-small cell lung cancer stage IIIB


subject: CHEMBL.COMPOUND:CHEMBL4297701


subject: UMLS:C4745025


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: coronary artery disorder


subject: CHEBI:37941

object_name: coronary atherosclerosis


subject: CHEBI:231679

subject_name: ipilimumab

object_name: castration-resistant prostate carcinoma


subject: CHEBI:231679

object_name: metastatic prostate carcinoma


subject: CHEBI:231679

object_name: Castration Levels of Testosterone


subject: CHEBI:231679

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:231679

object_name: PSA Progression


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pancreatic ductal adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: colorectal neoplasm


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C5962448

subject_name: Pan-KRAS Inhibitor PF-07934040


subject: UMLS:C5962448


subject: UMLS:C5962448


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:5931

subject_name: insulin human

object_name: Wound healed (finding)


subject: CHEBI:5931

object_name: Varicose Ulcer


subject: CHEBI:5931

object_name: varicose ulcer


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: UMLS:C0876064


subject: UMLS:C4744415

subject_name: PTPN11 Inhibitor RMC-4630

object_name: Solid Neoplasm


subject: UMLS:C0700346

subject_name: Koate-DVI

object_name: hemophilia A


subject: UMLS:C0700346

object_name: hemophilia


subject: GTOPDB:13630

subject_name: fitusiran


subject: GTOPDB:13630


subject: CHEMBL.COMPOUND:CHEMBL4297754

subject_name: FITUSIRAN


subject: CHEMBL.COMPOUND:CHEMBL4297754


subject: CHEBI:6933

subject_name: Midodrine

object_name: acute kidney failure


subject: CHEBI:6933

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:45863

object_name: endometrial carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:UYB6UOF69L

subject_name: Maralixibat

object_name: Alagille syndrome


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Ear Deformities, Acquired


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:231683

subject_name: Anakinra

object_name: cryopyrin-associated periodic syndrome


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:166975

subject_name: soybean oil

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:166975

object_name: obesity


subject: CHEBI:166975

object_name: Obesity, CTCAE


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: CHEBI:29321

subject_name: sodium nitroprusside

object_name: schizophrenia


subject: CHEBI:29321

object_name: schizoaffective disorder


subject: CHEBI:29321

object_name: schizophrenia 18


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:7465

subject_name: Naltrexone

object_name: methamphetamine dependence


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Postmenopausal symptoms


subject: CHEBI:32588

subject_name: Potassium chloride

object_name: Blood Pressure Finding


subject: CHEBI:32588

object_name: Systemic arterial pressure


subject: CHEBI:32588

object_name: hypertension


subject: CHEBI:32588

object_name: Hypertension, CTCAE


subject: UMLS:C5908550

subject_name: Active Substance


subject: UMLS:C5908550


subject: UMLS:C5908550


subject: UMLS:C5908550


subject: CHEBI:6801

subject_name: Metformin

object_name: liver carcinoma


subject: CHEBI:6801

object_name: Cirrhosis


subject: CHEBI:6801

object_name: chronic hepatitis C virus infection


subject: CHEBI:23359

subject_name: colchicine

object_name: coronary artery disorder


subject: CHEBI:23359

object_name: coronary atherosclerosis


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: hepatitis C


subject: CHEBI:499361

subject_name: Aprepitant

object_name: colorectal cancer


subject: CHEBI:499361

object_name: colorectal carcinoma


subject: CHEBI:499361

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:64321

subject_name: Fosaprepitant


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:174615

object_name: myeloproliferative neoplasm


subject: CHEBI:174615

object_name: Myelodysplasia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026

object_name: leukemia


subject: CHEBI:4026

object_name: childhood leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4659

subject_name: Disulfiram

object_name: alcohol abuse


subject: CHEBI:4659

object_name: alcohol dependence


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fractured rib


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: myelofibrosis


subject: UMLS:C0762110

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:231425

subject_name: tolvaptan


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: liver carcinoma


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: Hypoxemia


subject: UNII:X587FW0372

object_name: Hypoxia, CTCAE


subject: GTOPDB:12989

subject_name: toripalimab

object_name: gestational trophoblastic neoplasm


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID

object_name: pertussis


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: CHEMBL.COMPOUND:CHEMBL2109121

subject_name: DIPHTHERIA TOXOID


subject: UMLS:C0012551

subject_name: diphtheria toxoid vaccine, inactivated


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Childhood Breast Carcinoma


subject: CHEBI:4672

object_name: breast carcinoma


subject: CHEBI:4672

object_name: breast cancer


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: UMLS:C3272327

subject_name: Pradax

object_name: Thromboembolism


subject: CHEBI:4325

subject_name: Dapsone

object_name: acne


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: AL amyloidosis


subject: CHEBI:133021

subject_name: Venetoclax

object_name: plasma cell myeloma


subject: CHEBI:133021


subject: CHEMBL.COMPOUND:CHEMBL1237024

subject_name: SIPULEUCEL-T

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: prostate cancer


subject: CHEBI:39462

subject_name: pilocarpine

object_name: diabetes mellitus


subject: CHEBI:8207

subject_name: Pilocarpine


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Bladder cancer stage IV


subject: UNII:6XG22YQM2Z

object_name: Head and neck cancer metastatic


subject: UNII:6XG22YQM2Z

object_name: Metastatic non-small cell lung cancer


subject: UNII:6XG22YQM2Z

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:6XG22YQM2Z

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEBI:142708

object_name: Critical Illness


subject: CHEBI:142708

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: UMLS:C4526662

subject_name: SNS 062

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4526662

object_name: mantle cell lymphoma


subject: UMLS:C4526662

object_name: follicular lymphoma


subject: UMLS:C4526662

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4526662

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C4526662

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C4526662

object_name: marginal zone lymphoma


subject: UMLS:C4526662

object_name: MALT lymphoma


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: Dependence on dialysis due to end stage renal disease


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: multiple sclerosis


subject: CHEBI:4672

subject_name: Docetaxel

object_name: ovarian cancer


subject: CHEBI:4672

object_name: ovarian neoplasm


subject: CHEBI:4672

object_name: ovarian carcinoma


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:45783


subject: UMLS:C1310652

subject_name: Importal

object_name: HIV infection


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: Pancreatic carcinoma stage II


subject: CHEBI:114785

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:114785

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: Pancreatic carcinoma stage III


subject: CHEBI:114785

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: pancreatic adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Locally Advanced Colorectal Carcinoma


subject: UMLS:C1831883

object_name: colorectal carcinoma


subject: CHEBI:478164

subject_name: Cefepime

object_name: Complicated urinary tract infection


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Overweight


subject: CHEBI:46195

object_name: type 2 diabetes mellitus


subject: CHEBI:46195

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:46195

object_name: obesity


subject: CHEBI:46195

object_name: Obesity, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:194186

subject_name: Tirzepatide


subject: CHEBI:194186


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: urinary tract infection


subject: CHEBI:100241

object_name: bacterial urinary tract infection


subject: CHEBI:100241

object_name: urolithiasis


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:3062

object_name: prostate cancer


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: Clinical Response


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: HMDB:HMDB0247639

subject_name: Ileu-anp

object_name: Intraoperative Hemorrhage


subject: HMDB:HMDB0247639

object_name: Postoperative Hemorrhage, CTCAE


subject: HMDB:HMDB0247639

object_name: Postoperative Hemorrhage


subject: PUBCHEM.COMPOUND:156024996

subject_name: Trasylol


subject: PUBCHEM.COMPOUND:156024996


subject: PUBCHEM.COMPOUND:156024996


subject: UNII:04XPW8C0FL

subject_name: Aprotinin


subject: UNII:04XPW8C0FL


subject: UNII:04XPW8C0FL


subject: CHEBI:5391

subject_name: Glucagon

object_name: type 1 diabetes mellitus 1


subject: CHEBI:5391

object_name: type 1 diabetes mellitus


subject: CHEBI:5391

object_name: hypoglycemia


subject: CHEBI:5391

object_name: Blood glucose below reference range (finding)


subject: CHEBI:5391

object_name: Hypoglycemia, CTCAE


subject: PUBCHEM.COMPOUND:156963740

subject_name: Dasiglucagon


subject: PUBCHEM.COMPOUND:156963740


subject: PUBCHEM.COMPOUND:156963740


subject: PUBCHEM.COMPOUND:156963740


subject: PUBCHEM.COMPOUND:156963740


subject: UMLS:C5227685

object_name: hemophilia A


subject: UMLS:C5227685

object_name: hemophilia B


subject: UMLS:C5227685

object_name: hemophilia B leyden


subject: CHEBI:84363

object_name: type 2 diabetes mellitus


subject: CHEBI:2376

subject_name: acarbose


subject: PUBCHEM.COMPOUND:4432690

subject_name: Alpha-Acarbose


subject: UMLS:C4082329

subject_name: Glucobay


subject: CHEBI:135544

subject_name: Ilaprazole

object_name: Peptic Ulcer


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Myelodysplasia


subject: CHEBI:31355

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:31355

object_name: childhood myelodysplastic syndrome


subject: CHEBI:31355

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:31355

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:31355

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:31355

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:31355

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:31355

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:31355

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:31355

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:31355

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:31355

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:31355

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:31355

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:31355

object_name: adult acute monocytic leukemia


subject: CHEBI:31355

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:31355

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:31355

object_name: chronic myelomonocytic leukemia


subject: CHEBI:31355

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:31355

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:31355

object_name: Adult Erythroleukemia


subject: CHEBI:31355

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:31355

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:31355

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:31355

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:31355

object_name: essential thrombocythemia


subject: CHEBI:31355

object_name: acquired polycythemia vera


subject: CHEBI:63632

subject_name: Topotecan

object_name: Myelodysplasia


subject: CHEBI:63632

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:63632

object_name: childhood myelodysplastic syndrome


subject: CHEBI:63632

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:63632

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:63632

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:63632

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:63632

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:63632

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:63632

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:63632

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:63632

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:63632

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:63632

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:63632

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:63632

object_name: adult acute monocytic leukemia


subject: CHEBI:63632

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:63632

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:63632

object_name: chronic myelomonocytic leukemia


subject: CHEBI:63632

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:63632

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:63632

object_name: Adult Erythroleukemia


subject: CHEBI:63632

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:63632

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:63632

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:63632

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:63632

object_name: essential thrombocythemia


subject: CHEBI:63632

object_name: acquired polycythemia vera


subject: CHEBI:62880

subject_name: Veliparib

object_name: Myelodysplasia


subject: CHEBI:62880

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:62880

object_name: childhood myelodysplastic syndrome


subject: CHEBI:62880

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:62880

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:62880

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:62880

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:62880

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:62880

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:62880

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:62880

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:62880

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:62880

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:62880

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:62880

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:62880

object_name: adult acute monocytic leukemia


subject: CHEBI:62880

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:62880

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:62880

object_name: chronic myelomonocytic leukemia


subject: CHEBI:62880

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:62880

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:62880

object_name: Adult Erythroleukemia


subject: CHEBI:62880

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:62880

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:62880

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:62880

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:62880

object_name: essential thrombocythemia


subject: CHEBI:62880

object_name: acquired polycythemia vera


subject: CHEBI:63633

subject_name: Triptorelin

object_name: ovarian hyperstimulation syndrome


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate


subject: GTOPDB:1160

subject_name: hCG


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1704298

subject_name: Recombinant Luteinizing Hormone


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:45783

subject_name: Imatinib

object_name: type C thymoma


subject: UMLS:C5814348

object_name: hemophilia B


subject: UMLS:C5814348

object_name: hemophilia B leyden


subject: UMLS:C4309517

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4309517

object_name: non-Hodgkin lymphoma


subject: UNII:6ZJ8V3Q0H1


subject: UNII:6ZJ8V3Q0H1


subject: CHEBI:135466

subject_name: Nafamostat

object_name: Extracorporeal membrane oxygenation complication


subject: UMLS:C0207682

subject_name: nafamostat mesilate


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: influenza


subject: UMLS:C4318638

subject_name: Quadrivalent Influenza Vaccine


subject: UMLS:C1330606

subject_name: Wellbutrin XL

object_name: Depressed mood


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: Rhinosinusitis


subject: MESH:D012462

object_name: otorhinolaryngologic disease


subject: UMLS:C0770261

subject_name: Dextrose 20% and Water

object_name: type 2 diabetes mellitus


subject: UMLS:C0770261

object_name: Insulin resistance


subject: UMLS:C0770261

object_name: hyperinsulinism


subject: UMLS:C0770261

object_name: Hyperinsulinemia


subject: UMLS:C0770261

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0770261

object_name: obesity


subject: UMLS:C0770261

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:5391


subject: CHEBI:5391


subject: CHEBI:5391


subject: CHEBI:5391


subject: CHEBI:5391


subject: CHEBI:5391


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: UMLS:C0021641

subject_name: Insulin


subject: UMLS:C0021641


subject: UMLS:C0021641


subject: UMLS:C0021641


subject: UMLS:C0021641


subject: UMLS:C0021641


subject: UMLS:C0021641


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: UNII:80YS8O1MBS

subject_name: CISATRACURIUM BESYLATE

object_name: no feeling or sensation of skin


subject: UNII:80YS8O1MBS

object_name: Sensory Loss


subject: CHEBI:140621

subject_name: Cisatracurium


subject: CHEBI:140621


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:31355

subject_name: Carboplatin

object_name: adult lymphoma


subject: CHEBI:31355

object_name: lymphoma


subject: CHEBI:31355

object_name: pediatric lymphoma


subject: CHEBI:31355

object_name: Drug toxicity


subject: CHEBI:31355

object_name: thrombocytopenia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: atrial fibrillation


subject: CHEBI:70746

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:70746

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:70746

object_name: myocardial infarction


subject: CHEBI:70746

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:70746

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:70746

object_name: coronary artery disorder


subject: CHEBI:70746

object_name: coronary atherosclerosis


subject: CHEBI:70746

object_name: myocardial ischemia


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: UMLS:C1134696

object_name: Stomach cancer


subject: UMLS:C1134696

object_name: gastric cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C1134696

object_name: non-small cell lung carcinoma


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: periodontitis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: nasopharyngeal carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: hypogonadism


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:17347

subject_name: Testosterone


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: UMLS:C3180499

subject_name: Targinact

object_name: Post-Operative Pain


subject: UMLS:C3180499

object_name: post operative nausea and vomiting


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: castration-resistant prostate carcinoma


subject: CHEBI:68534

object_name: Stage IVB Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C5389886

subject_name: hyaluronidase-zzxf


subject: UMLS:C5389886


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: CHEBI:28918

subject_name: Epinephrine

object_name: acute pancreatitis


subject: CHEBI:72323

subject_name: Alogliptin

object_name: type 2 diabetes mellitus


subject: CHEBI:23359

subject_name: colchicine

object_name: Myocardial injury


subject: CHEBI:23359

object_name: myocardial infarction


subject: CHEBI:23359

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:23359

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:23359

object_name: Major Adverse Cardiac Events


subject: UMLS:C2703149

object_name: osteoporosis


subject: UMLS:C2703149

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C2703149

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C2703149

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:6887


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR


subject: PUBCHEM.COMPOUND:3043660


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: CHEBI:71272

subject_name: Saxagliptin


subject: CHEBI:600103

subject_name: daptomycin

object_name: skin disorder caused by infection


subject: CHEBI:600103

object_name: skin infection


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Tooth extraction status NOS


subject: CHEBI:41879

object_name: Radicular Cyst


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: liver carcinoma


subject: UMLS:C3896924

subject_name: Anti-CD19/CD3 Tetravalent Antibody AFM11

object_name: B-cell lymphoma refractory


subject: CHEBI:90205

subject_name: Plitidepsin


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: UMLS:C0388638

subject_name: plitidepsin


subject: PUBCHEM.COMPOUND:57748689

object_name: cancer


subject: PUBCHEM.COMPOUND:57748689

object_name: neoplasm


subject: UNII:7M346920EV


subject: UNII:7M346920EV


subject: UMLS:C1831859

subject_name: Oligofructose-Enriched Inulin

object_name: chronic kidney disease


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: acute myeloid leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: plasma cell myeloma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:65346

subject_name: Aclidinium

object_name: chronic obstructive pulmonary disease


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:4026

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:4026

object_name: rhabdomyosarcoma


subject: CHEBI:4026

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:4026

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: malignant pancreatic neoplasm


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: colorectal cancer


subject: CHEBI:191174

object_name: colorectal carcinoma


subject: CHEBI:191174

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:78538

object_name: Adhesive Capsulitis


subject: CHEBI:78538

object_name: frozen shoulder


subject: CHEBI:78538

object_name: bursitis


subject: CHEBI:78538

object_name: Osteoarthritis of glenohumeral joint


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: pemphigus vulgaris


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: granulomatosis with polyangiitis


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: EXCESS LMW-DNA


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: Erosive esophagitis


subject: CHEBI:135931

object_name: Heartburn


subject: CHEBI:135931

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: chronic pain syndrome


subject: CHEBI:89324

object_name: vitamin D deficiency


subject: CHEBI:89324

object_name: Inflammatory Response


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:367163

subject_name: Darunavir

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: CHEBI:31536

subject_name: Emtricitabine


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:73629

subject_name: Phe-Asp-Cys


subject: CHEBI:38848

subject_name: perflunafene


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Rheumatism


subject: MESH:D000086663

object_name: hematologic disorder


subject: MESH:D000086663

object_name: nervous system disorder


subject: MESH:D000086663

object_name: Childhood Solid Neoplasm


subject: MESH:D000086663

object_name: Adult Solid Neoplasm


subject: MESH:D000086663

object_name: Solid Neoplasm


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: CHEBI:601027

subject_name: Aliskiren

object_name: coronary artery disorder


subject: CHEBI:601027

object_name: coronary atherosclerosis


subject: CHEBI:34741

subject_name: Equol

object_name: chronic kidney disease


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: PUBCHEM.COMPOUND:70789204

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:70789204

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:50913622

subject_name: Delgocitinib

object_name: atopic eczema


subject: CHEBI:23359

subject_name: colchicine

object_name: Heart failure with normal ejection fraction


subject: CHEBI:6413

subject_name: Letrozole

object_name: Androgen excess


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Postoperative Pain, Chronic


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C1608323

subject_name: Emtricitabine/ Tenofovir Disoproxil Fumarate

object_name: HIV infection


subject: UMLS:C0717880

subject_name: lamivudine / zidovudine


subject: CHEBI:145924

subject_name: Kaletra


subject: UMLS:C0939237

subject_name: lopinavir / ritonavir


subject: CHEBI:190008

subject_name: Tianeptine


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: IgA Nephropathy


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: chronic hepatitis C virus infection


subject: UNII:G8RGG88B68


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:70839

subject_name: Dasatinib

object_name: triple-negative breast carcinoma


subject: CHEBI:70839

object_name: breast neoplasm


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:6456

subject_name: Lidocaine

object_name: inflammatory bowel disease


subject: CHEBI:6456

object_name: colon carcinoma


subject: CHEBI:6456

object_name: colorectal cancer


subject: CHEBI:6456

object_name: colon cancer


subject: CHEBI:6456

object_name: diverticulitis


subject: UMLS:C0700605

subject_name: Desogen (contraceptive)

object_name: Vaginal epithelial disruption


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4453

subject_name: Desogestrel


subject: PUBCHEM.COMPOUND:9960701

subject_name: NuvaRing


subject: CHEBI:50777

subject_name: Etonogestrel


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: hyperphosphatemia


subject: UNII:4B33BGI082

object_name: Serum phosphate concentrations above normal (finding)


subject: UNII:4B33BGI082

object_name: Hyperphosphatemia, CTCAE


subject: UNII:4B33BGI082

object_name: Complication of hemodialysis


subject: UNII:4B33BGI082

object_name: chronic kidney disease


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Mechanical ventilation finding


subject: CHEBI:16919

subject_name: Creatine

object_name: concussion


subject: CHEBI:31709

subject_name: Iohexol

object_name: acute kidney failure


subject: CHEBI:35341

subject_name: steroid

object_name: ulcerative colitis


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Childhood Astrocytoma


subject: UMLS:C0919079

object_name: astrocytic tumor


subject: UMLS:C0919079

object_name: astrocytoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:231683

subject_name: Anakinra

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:231683

object_name: obesity


subject: CHEBI:231683

object_name: Obesity, CTCAE


subject: CHEBI:231683

object_name: hypogonadism


subject: CHEBI:231683

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:231683

object_name: metabolic syndrome X


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UMLS:C4053663

object_name: non-small cell lung carcinoma


subject: UNII:CI43QFE22O

object_name: Childhood Diffuse Intrinsic Pontine Glioma


subject: UNII:CI43QFE22O

object_name: Childhood Diffuse Midline Glioma


subject: UNII:CI43QFE22O

object_name: pediatric high-grade glioma


subject: UNII:CI43QFE22O

object_name: Childhood Glioblastoma


subject: UNII:CI43QFE22O


subject: PUBCHEM.COMPOUND:146025939

subject_name: Belumosudil Mesylate

object_name: plasma cell myeloma


subject: UNII:834YJF89WO

subject_name: Belumosudil


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: schizophrenia


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: female reproductive system neoplasm


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: CHEBI:85164


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C5667104

subject_name: EGFR Inhibitor NRC-2694 Hydrochloride

object_name: carcinoma


subject: CHEBI:45863


subject: UMLS:C3713109

object_name: HIV infection


subject: CHEBI:172944

subject_name: Cabotegravir


subject: UMLS:C0662900

object_name: female infertility of uterine origin


subject: CHEBI:125354

subject_name: Plerixafor


subject: UMLS:C1831819

object_name: Neck Carcinoma


subject: UMLS:C1831819

object_name: head and neck neoplasm


subject: UMLS:C1831819

object_name: head and neck cancer


subject: UMLS:C1831819

object_name: squamous cell neoplasm


subject: UMLS:C1831819

object_name: squamous cell carcinoma


subject: UMLS:C1831819

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1831819

object_name: mouth neoplasm


subject: CHEBI:8746

subject_name: Levosalbutamol

object_name: asthma


subject: UMLS:C5782769

subject_name: BUPivacaine 0.5% injectable solution

object_name: Anterior Cruciate Ligament Injuries


subject: UMLS:C0308803

subject_name: dexamethasone injection


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: Muscle function outcome


subject: UMLS:C0000392

subject_name: beta-alanine


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Adult Solid Neoplasm


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:28241

subject_name: Papaverine

object_name: no feeling or sensation of skin


subject: CHEBI:28241

object_name: Sensory Loss


subject: CHEBI:28241

object_name: Vasospasm


subject: CHEBI:49662

subject_name: Indomethacin

object_name: preterm premature rupture of the membranes


subject: UMLS:C5417912

subject_name: MEK 1/2 Inhibitor FCN-159

object_name: Neoplasm of nerve sheath origin


subject: UMLS:C5417912

object_name: nerve sheath neoplasm


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: urothelial carcinoma


subject: UNII:52CMI0WC3Y

object_name: transitional cell carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:98BSN6N516

subject_name: Rogaratinib


subject: UNII:98BSN6N516


subject: UMLS:C5198671


subject: UMLS:C5198671


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: non-small cell lung carcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: skin melanoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: chronic kidney disease


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:71953

object_name: Childhood Breast Carcinoma


subject: CHEBI:71953

object_name: breast carcinoma


subject: CHEBI:71953

object_name: breast cancer


subject: CHEBI:71953

object_name: Solid Neoplasm


subject: CHEBI:71953

object_name: Cowden disease


subject: UMLS:C2347426


subject: UMLS:C2347426


subject: UMLS:C2347426


subject: UMLS:C2347426


subject: UMLS:C2347426


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Torticollis


subject: DRUGBANK:DB17768

object_name: recurrent respiratory papillomatosis


subject: UMLS:C5833413

subject_name: Modified Vitamin D Binding Protein Macrophage Activator


subject: UMLS:C0876128

subject_name: Plan B

object_name: Pregnant


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:63577

subject_name: Lamivudine

object_name: HIV infection


subject: CHEBI:7575

subject_name: Nimodipine

object_name: cocaine abuse


subject: UMLS:C1614973

object_name: Alzheimer disease type 1


subject: UMLS:C1614973

object_name: Alzheimer disease


subject: UNII:82P4S8Q3FB

subject_name: SOCAZOLIMAB

object_name: cervical cancer


subject: UNII:82P4S8Q3FB

object_name: cervical carcinoma


subject: UMLS:C5206606

subject_name: STI A1014


subject: UMLS:C5206606


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: Parkinson disease


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: CHEBI:74088


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: type 1 diabetes mellitus


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: CHEBI:5931

subject_name: insulin human


subject: UMLS:C0123677

subject_name: NovoLog


subject: CHEBI:63613

subject_name: Nevirapine

object_name: liver failure


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Blood Pressure Finding


subject: CHEBI:33569

object_name: Systemic arterial pressure


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:145499

subject_name: Donepezil

object_name: Bilateral sensorineural hearing impairment


subject: UMLS:C0876064

subject_name: Lantus

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:156768862

object_name: Non-cystic fibrosis bronchiectasis


subject: CHEBI:8382

subject_name: Prednisone

object_name: temporal arteritis


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:KX7ZYR6OQW

subject_name: ENADENOTUCIREV

object_name: Bladder cancer stage IV


subject: UNII:KX7ZYR6OQW

object_name: metastatic colorectal cancer


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: non-small cell lung carcinoma


subject: UMLS:C1948073


subject: UNII:VX6GTS64AJ


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: cystic fibrosis


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: intestinal disorder


subject: CHEBI:3125

object_name: colon adenoma


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: DRUGBANK:DB15843

subject_name: CVnCoV Vaccine


subject: DRUGBANK:DB15843

object_name: severe acute respiratory syndrome


subject: DRUGBANK:DB15843

object_name: Coronavinae infectious disease


subject: MESH:C000722934

subject_name: CVnCoV COVID-19 vaccine


subject: MESH:C000722934


subject: MESH:C000722934


subject: CHEMBL.COMPOUND:CHEMBL2108918

subject_name: CHAMOMILE

object_name: Infantile Colic


subject: CHEBI:18388

subject_name: Apigenin


subject: UMLS:C1831909

subject_name: Cantuzumab ravtansine

object_name: pancreatic neoplasm


subject: UMLS:C1831909

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1831909

object_name: malignant pancreatic neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:31348

subject_name: Capecitabine


subject: UNII:94X46KW4AE

subject_name: Amenamevir

object_name: herpes simplex


subject: UMLS:C3640060

subject_name: Aneustat

object_name: neoplasm


subject: UMLS:C3640059

subject_name: Multifunctional/Multitargeted Anticancer Agent OMN54


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Anaesthesia intubation complication


subject: UNII:Z4HZ70S62Q

subject_name: Unesbulin

object_name: cancer


subject: UNII:Z4HZ70S62Q


subject: CHEBI:91951

object_name: Childhood Breast Carcinoma


subject: CHEBI:91951

object_name: breast carcinoma


subject: CHEBI:91951

object_name: breast cancer


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:36796

subject_name: duloxetine

object_name: Cancer patients and suicide and depression


subject: CHEBI:36796

object_name: Depressed - symptom


subject: CHEBI:36796

object_name: Depression, CTCAE


subject: CHEBI:36796

object_name: dysthymic disorder


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Breast cancer recurrent


subject: UNII:2285XW22DR

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:2285XW22DR

object_name: male breast carcinoma


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: UNII:7IK8Z952OK

subject_name: Plecanatide

object_name: Irritable bowel syndrome characterized by constipation


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: lymphoid leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:87715

subject_name: Prasugrel

object_name: myocardial infarction


subject: CHEBI:87715

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:87715

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:71940

subject_name: Tadalafil

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:18772499

object_name: Insulin resistance


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: osteoarthritis, knee


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Impacted third molar tooth


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY


subject: UNII:KT0ZQ64X1A

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: Nausea, CTCAE_5


subject: CHEBI:184693

object_name: Nausea


subject: CHEBI:184693

object_name: Nausea, CTCAE_3


subject: CHEBI:184693

object_name: Perioperative complication


subject: CHEBI:184693

object_name: Vomiting, Postoperative


subject: CHEBI:184693

object_name: bariatric surgery candidate


subject: CHEBI:184693

object_name: Drug action (disorder)


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: PUBCHEM.COMPOUND:3367

object_name: sickle cell disease


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:215747

subject_name: Tapinarof

object_name: Chronic small plaque psoriasis


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: HER2 positive breast carcinoma


subject: CHEBI:5062

subject_name: Finasteride

object_name: prostate carcinoma


subject: CHEBI:5062

object_name: prostate cancer


subject: CHEBI:85990

subject_name: Panobinostat

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:85990

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:85990

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:85990

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:85990

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:85990

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:85990

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: UMLS:C5961048

subject_name: CLK Inhibitor BH-30236

object_name: leukemia


subject: UMLS:C5961048

object_name: childhood leukemia


subject: UMLS:C5961048

object_name: Myelodysplasia


subject: UMLS:C5961048

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5961048

object_name: myeloid leukemia


subject: UMLS:C5961048

object_name: acute myeloid leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: KEGG.COMPOUND:C02380

object_name: acute lymphoblastic leukemia


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: PUBCHEM.COMPOUND:5289549

object_name: secondary hyperparathyroidism


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Acute Stroke


subject: UNII:1RXS4UE564

object_name: Acute Stroke Related to COVID-19


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C4078792

object_name: COPD, severe early onset


subject: UMLS:C4078792

object_name: chronic obstructive pulmonary disease


subject: CHEBI:10033

subject_name: Warfarin

object_name: venous thromboembolism


subject: CHEBI:10033

object_name: thrombophilia due to thrombin defect


subject: CHEBI:10033

object_name: Thromboembolism


subject: CHEBI:10033

object_name: peripheral vascular disease


subject: CHEBI:10033

object_name: cardiovascular disorder


subject: CHEBI:10033

object_name: aneurysm


subject: CHEBI:10033

object_name: heart disorder


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: HIV infection


subject: CHEBI:465284

object_name: cytomegalovirus infection


subject: CHEBI:27470

subject_name: Folic acid

object_name: acute kidney failure


subject: CHEBI:27470

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Feeding Disorders


subject: CHEBI:60802

object_name: cancer


subject: CHEBI:60802

object_name: neoplasm


subject: CHEBI:7774

subject_name: Zofran

object_name: Mycobacterium avium complex disease


subject: CHEBI:7774

object_name: Adverse effects


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:367163

subject_name: Darunavir

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:367163

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: PUBCHEM.COMPOUND:57414794


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: PUBCHEM.COMPOUND:72370618


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:60481


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000008953


subject: UNII:2XD9773ZMN

subject_name: Tonabersat

object_name: long COVID-19


subject: CHEBI:90942

subject_name: Ixazomib

object_name: plasma cell myeloma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:85154

subject_name: Akynzeo

object_name: Chemotherapy-induced nausea and vomiting


subject: RXCUI:1552339

subject_name: netupitant / palonosetron Oral Product


subject: UMLS:C4305818

object_name: typhoid fever


subject: CHEBI:52717

subject_name: Bortezomib

object_name: pancreatic neuroendocrine neoplasm


subject: CHEBI:52717

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:52717

object_name: Gastrointestinal Carcinoid Tumor


subject: UMLS:C5222443

subject_name: Fulvestrant Injection

object_name: Childhood Breast Carcinoma


subject: UMLS:C5222443

object_name: breast carcinoma


subject: UMLS:C5222443

object_name: breast cancer


subject: UMLS:C5417840

subject_name: ATR Kinase Inhibitor M1774


subject: UMLS:C5417840


subject: UMLS:C5417840


subject: CHEBI:5931

subject_name: insulin human

object_name: Diabetes


subject: UMLS:C0123677

subject_name: NovoLog

object_name: type 2 diabetes mellitus


subject: UMLS:C0123677


subject: UMLS:C0123677

object_name: diabetes mellitus


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: sickle cell disease


subject: UNII:SQ8A3S5101

object_name: HbS hemoglobin


subject: UNII:SQ8A3S5101

object_name: Hemoglobin S Measurement


subject: UNII:SQ8A3S5101

object_name: HEMOGLOBIN S PHENOTYPE


subject: UNII:IZ2GRM2YZB

object_name: endometriosis


subject: PUBCHEM.COMPOUND:633091

subject_name: Aristospan

object_name: Cellular infiltrate


subject: PUBCHEM.COMPOUND:633091

object_name: Infiltration


subject: PUBCHEM.COMPOUND:633091

object_name: Osteoarthritis of glenohumeral joint


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEBI:150712


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:4672

subject_name: Docetaxel

object_name: esophageal adenocarcinoma


subject: CHEBI:4672

object_name: gastric adenocarcinoma


subject: CHEBI:4672

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:4672


subject: UMLS:C5962492

subject_name: Anti-EpCAM/Anti-CD40 Bispecific Antibody KK2269


subject: UMLS:C5962492


subject: UMLS:C5962492


subject: UMLS:C5962492

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5962492


subject: UMLS:C5962492

object_name: non-small cell lung carcinoma


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: neovascular glaucoma


subject: UNII:ZL1R02VT79

object_name: proliferative diabetic retinopathy


subject: UNII:ZL1R02VT79

object_name: macular degeneration


subject: UNII:ZL1R02VT79

object_name: retinitis pigmentosa 30


subject: UNII:ZL1R02VT79

object_name: macular holes


subject: CHEBI:6129

subject_name: Ketorolac

object_name: migraine


subject: CHEBI:6129

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:125628

subject_name: Alisertib

object_name: Carcinoma breast stage IV


subject: CHEBI:125628

object_name: Breast cancer recurrent


subject: CHEBI:125628

object_name: hormone receptor-positive breast cancer


subject: CHEBI:125628

object_name: Hormone receptor negative HER2 positive breast cancer


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS


subject: UMLS:C3540795


subject: UMLS:C2684473

subject_name: coffee bean extract

object_name: Overweight and obesity


subject: GTOPDB:8264

subject_name: fresolimumab

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: GTOPDB:8264

object_name: stage IB non-small cell lung cancer


subject: GTOPDB:8264

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: UNII:375142VBIA


subject: UNII:375142VBIA


subject: UNII:375142VBIA


subject: UMLS:C1832030


subject: UMLS:C1832030


subject: UMLS:C1832030


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: wet macular degeneration


subject: PUBCHEM.COMPOUND:146170995

subject_name: Glepaglutide

object_name: short bowel syndrome


subject: DRUGBANK:DB14794


subject: CHEBI:49668

subject_name: Gefitinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:49668

object_name: non-small cell lung carcinoma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:33364

subject_name: Platinum


subject: CHEBI:33364


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UMLS:C1171558


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:46783403

object_name: blood coagulation disease


subject: PUBCHEM.COMPOUND:46783403

object_name: Endotoxemia


subject: PUBCHEM.COMPOUND:46783403

object_name: inherited bleeding disorder, platelet-type


subject: PUBCHEM.COMPOUND:46783403

object_name: blood platelet disease


subject: RXCUI:659877

subject_name: Gardasil

object_name: cervical cancer


subject: RXCUI:659877

object_name: cervical carcinoma


subject: RXCUI:659877

object_name: human papilloma virus infection


subject: PR:000017295

subject_name: von Hippel-Lindau-like protein


subject: PR:000017295


subject: PR:000017295


subject: PR:000031824

subject_name: probable serine carboxypeptidase CPVL


subject: PR:000031824


subject: PR:000031824


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: multiple sclerosis


subject: UNII:A10SJL62JY

object_name: Clinically isolated syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108693

subject_name: SYRUP

object_name: Acute respiratory infections


subject: CHEMBL.COMPOUND:CHEMBL2108693

object_name: influenza


subject: CHEMBL.COMPOUND:CHEMBL2108693

object_name: common cold


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Schizophrenic psychoses


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6432

subject_name: Levamisole


subject: UNII:3HP012Q0FH

object_name: macular degeneration


subject: UNII:3HP012Q0FH

object_name: age-related macular degeneration


subject: UNII:3HP012Q0FH

object_name: retinitis pigmentosa 30


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: UNII:2H1PA8H1EN


subject: UNII:2H1PA8H1EN


subject: UMLS:C4744361

subject_name: AKT Inhibitor

object_name: cancer


subject: UMLS:C4744361

object_name: neoplasm


subject: UMLS:C4744361

object_name: type 2 diabetes mellitus


subject: UMLS:C4744361

object_name: Insulin resistance


subject: UMLS:C4744361

object_name: MTOR Gene Mutation


subject: UMLS:C4744361

object_name: PIK3CA Gene Mutation


subject: UMLS:C4744361

object_name: PI3K Gene Mutation


subject: UMLS:C4744361

object_name: AKT Family Gene Mutation


subject: UMLS:C4744361

object_name: AKT1 Gene Mutation


subject: CHEBI:47458

subject_name: Saracatinib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:47458

object_name: Prostate cancer recurrent


subject: CHEBI:47458

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:47458

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:47458

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:47458

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM

object_name: chronic obstructive pulmonary disease


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: PUBCHEM.COMPOUND:9919001

subject_name: FORMOTEROL FUMARATE


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: Sturge-Weber syndrome


subject: CHEBI:39465

subject_name: timolol


subject: UNII:U946SH95EE

subject_name: Milk thistle

object_name: diabetic kidney disease


subject: UNII:3S252O2Z4X

subject_name: Emapalumab

object_name: macrophage activation syndrome


subject: UNII:3S252O2Z4X

object_name: juvenile idiopathic arthritis


subject: UNII:3S252O2Z4X

object_name: adult-onset Still disease


subject: UNII:3S252O2Z4X

object_name: hemophagocytic syndrome


subject: UMLS:C4740903

subject_name: emapalumab-lzsg


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: secondary progressive multiple sclerosis


subject: CHEBI:7769

subject_name: Olopatadine

object_name: atopic conjunctivitis


subject: CHEBI:7769

object_name: Atopic rhinitis


subject: CHEBI:7769

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:499361

subject_name: Aprepitant

object_name: heart failure


subject: CHEBI:499361

object_name: Heart Failure, CTCAE


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C2933615


subject: CHEBI:64703

subject_name: p-aminohippurate


subject: CHEBI:64703


subject: CHEBI:104011

subject_name: Aminohippuric acid


subject: CHEBI:104011


subject: UMLS:C0700551

subject_name: aminohippurate sodium


subject: UMLS:C0700551


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: KRAS Gene Mutation Negative


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:27470

subject_name: Folic acid

object_name: colorectal cancer


subject: CHEBI:27470

object_name: colorectal carcinoma


subject: CHEBI:27470

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:27470


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:04XPW8C0FL

subject_name: Aprotinin

object_name: pancreatitis


subject: UNII:04XPW8C0FL

object_name: Pancreatitis, CTCAE 5.0


subject: UNII:04XPW8C0FL

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:231614

subject_name: Nivolumab

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:231614

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:231614

object_name: Plasma cell myeloma refractory


subject: CHEBI:231614

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:231614

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:231614

object_name: Advanced Lymphoma


subject: CHEBI:231614

object_name: Refractory Lymphoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:60481

object_name: HIV-1 infection


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: CHEBI:32139

object_name: chronic kidney disease


subject: CHEBI:32139

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:32139

object_name: metabolic acidosis


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: carcinoma of esophagus


subject: UNII:PQX0D8J21J

object_name: esophageal cancer


subject: UNII:PQX0D8J21J

object_name: Childhood Esophageal Carcinoma


subject: UNII:PQX0D8J21J

object_name: neoplasm of esophagus


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: kidney neoplasm


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:6QPN83HK2M

subject_name: Berubicin

object_name: adult glioblastoma


subject: CHEBI:6942

subject_name: Minoxidil

object_name: Frontal balding


subject: CHEBI:132975

subject_name: Grazoprevir

object_name: hepatitis C


subject: CHEBI:132975

object_name: chronic hepatitis C virus infection


subject: MESH:C568859

object_name: open-angle glaucoma


subject: MESH:C568859

object_name: ocular hypertension


subject: MESH:C568859

object_name: Ocular hypertension


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Plasma cell myeloma refractory


subject: CHEBI:4026

object_name: Plasma cell myeloma recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Overweight


subject: CHEBI:37941

object_name: cardiovascular disorder


subject: UNII:RC2V4W0EYC

subject_name: Buloxibutid

object_name: coronary microvascular disorder


subject: GTOPDB:7037


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:3086655

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: PUBCHEM.COMPOUND:11431811


subject: PUBCHEM.COMPOUND:9800339

subject_name: Olodaterol


subject: PUBCHEM.COMPOUND:9800339


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: ovarian cancer


subject: CHEBI:28748

object_name: ovarian neoplasm


subject: CHEBI:28748

object_name: ovarian carcinoma


subject: CHEBI:28748

object_name: fallopian tube carcinoma


subject: CHEBI:28748

object_name: fallopian tube cancer


subject: CHEBI:28748

object_name: Carcinoma of peritoneum


subject: CHEBI:28748

object_name: peritoneal carcinoma


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: UMLS:C4085979

object_name: lung neoplasm


subject: MESH:D001152

subject_name: Arsenicals

object_name: liver carcinoma


subject: MESH:D001152

object_name: Klatskin Tumor


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: COVID-19 respiratory infection


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910

object_name: Solid Neoplasm


subject: CHEBI:66910

object_name: non-small cell lung carcinoma


subject: UMLS:C4053606

subject_name: Ivuxolimab


subject: UMLS:C4053606


subject: UMLS:C4053606


subject: UMLS:C4053606


subject: UMLS:C4053606


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:9244

subject_name: utomilumab


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: CHEBI:195280

subject_name: Artemether

object_name: malaria


subject: CHEBI:195280

object_name: HIV infection


subject: CHEBI:156095

subject_name: Lumefantrine


subject: CHEBI:156095


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:119486


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:45409

subject_name: Ritonavir


subject: PR:000022848

subject_name: guanosine-inosine kinase

object_name: herpes zoster


subject: PR:000022848

object_name: influenza


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: UniProtKB:P0AEW6


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: UMLS:C0770694


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: metastatic colorectal cancer


subject: UNII:7UQ7X4Y489

object_name: Thromboembolism


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: anus cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: anal carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: vulva cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: vulva carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: skin squamous cell carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: skin melanoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: anus cancer


subject: UNII:C4V974V932

object_name: anal carcinoma


subject: UNII:C4V974V932

object_name: ovarian cancer


subject: UNII:C4V974V932

object_name: ovarian neoplasm


subject: UNII:C4V974V932

object_name: vulva cancer


subject: UNII:C4V974V932

object_name: vulva carcinoma


subject: UNII:C4V974V932

object_name: cervical cancer


subject: UNII:C4V974V932

object_name: cervical carcinoma


subject: UNII:C4V974V932

object_name: rectal carcinoma


subject: UNII:C4V974V932

object_name: rectal cancer


subject: UNII:C4V974V932

object_name: Neck Carcinoma


subject: UNII:C4V974V932

object_name: head and neck neoplasm


subject: UNII:C4V974V932

object_name: head and neck cancer


subject: UNII:C4V974V932

object_name: endometrial cancer


subject: UNII:C4V974V932

object_name: endometrial carcinoma


subject: UNII:C4V974V932

object_name: skin squamous cell carcinoma


subject: UNII:C4V974V932

object_name: breast carcinoma


subject: UNII:C4V974V932

object_name: skin melanoma


subject: MESH:C000615519

object_name: anus cancer


subject: MESH:C000615519

object_name: anal carcinoma


subject: MESH:C000615519

object_name: ovarian cancer


subject: MESH:C000615519

object_name: ovarian neoplasm


subject: MESH:C000615519

object_name: vulva cancer


subject: MESH:C000615519

object_name: vulva carcinoma


subject: MESH:C000615519

object_name: cervical cancer


subject: MESH:C000615519

object_name: cervical carcinoma


subject: MESH:C000615519

object_name: rectal carcinoma


subject: MESH:C000615519

object_name: rectal cancer


subject: MESH:C000615519

object_name: Neck Carcinoma


subject: MESH:C000615519

object_name: head and neck neoplasm


subject: MESH:C000615519

object_name: head and neck cancer


subject: MESH:C000615519

object_name: endometrial cancer


subject: MESH:C000615519

object_name: endometrial carcinoma


subject: MESH:C000615519

object_name: skin squamous cell carcinoma


subject: MESH:C000615519

object_name: breast carcinoma


subject: MESH:C000615519

object_name: skin melanoma


subject: CHEBI:33353

subject_name: technetium atom

object_name: anus cancer


subject: CHEBI:33353

object_name: anal carcinoma


subject: CHEBI:33353

object_name: ovarian cancer


subject: CHEBI:33353

object_name: ovarian neoplasm


subject: CHEBI:33353

object_name: vulva cancer


subject: CHEBI:33353

object_name: vulva carcinoma


subject: CHEBI:33353

object_name: cervical cancer


subject: CHEBI:33353

object_name: cervical carcinoma


subject: CHEBI:33353

object_name: rectal carcinoma


subject: CHEBI:33353

object_name: rectal cancer


subject: CHEBI:33353

object_name: Neck Carcinoma


subject: CHEBI:33353

object_name: head and neck neoplasm


subject: CHEBI:33353

object_name: head and neck cancer


subject: CHEBI:33353

object_name: endometrial cancer


subject: CHEBI:33353

object_name: endometrial carcinoma


subject: CHEBI:33353

object_name: skin squamous cell carcinoma


subject: CHEBI:33353

object_name: breast carcinoma


subject: CHEBI:33353

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: kidney failure


subject: CHEBI:61033

subject_name: Fondaparinux


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Hypercholesterolemia


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Pregnant


subject: CHEBI:86465

subject_name: Kalinite

object_name: nicotine dependence


subject: UNII:I7T908772F

subject_name: alum


subject: CHEBI:86463

subject_name: Potassium alum


subject: CHEBI:61397

subject_name: Neratinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:61397


subject: CHEBI:61397

object_name: breast cancer


subject: CHEBI:61397

object_name: HER2 positive breast carcinoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: schizophrenia


subject: MESH:C044237

subject_name: Haemophilus influenzae type b polysaccharide vaccine

object_name: poliomyelitis


subject: MESH:C044237

object_name: hepatitis B


subject: MESH:C044237

object_name: diphtheria


subject: MESH:C044237

object_name: tetanus


subject: UMLS:C0066928

subject_name: mullerian-inhibiting hormone

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: osteoporosis risk


subject: PUBCHEM.COMPOUND:70789204

object_name: Osteopenia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Myelodysplasia, CTCAE


subject: CHEBI:4026

object_name: acute leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: Inguinal hernia


subject: CHEBI:36333

object_name: Post-Operative Pain


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: UMLS:C3536836


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: sleep disorder


subject: UNII:4B3SC438HI

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:4B3SC438HI

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:4B3SC438HI

object_name: Malignant Solid Neoplasm


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6887


subject: CHEBI:6887


subject: CHEBI:6887


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: endogenous depression


subject: UMLS:C0770694

object_name: major depressive disorder


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: CHEBI:31355

subject_name: Carboplatin

object_name: squamous cell carcinoma


subject: CHEBI:31355

object_name: lip and oral cavity carcinoma


subject: CHEBI:31355

object_name: oral cavity cancer


subject: CHEBI:31355

object_name: lip cancer


subject: CHEBI:31355

object_name: Lip Carcinoma


subject: CHEBI:31355

object_name: laryngeal carcinoma


subject: CHEBI:31355

object_name: larynx cancer


subject: CHEBI:31355

object_name: carcinoma of esophagus


subject: CHEBI:31355

object_name: esophageal cancer


subject: CHEBI:31355

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:31355

object_name: neoplasm of esophagus


subject: CHEBI:31355

object_name: oropharyngeal carcinoma


subject: CHEBI:31355

object_name: oropharynx cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Myelodysplasia